iASPP overexpression is associated with clinical outcome in spinal chordoma and influences cellular proliferation, invasion, and sensitivity to cisplatin in vitro

The oncogenetic function of inhibitory member of the apoptosis stimulating protein of p53 family (iASPP) in chordoma is unclear and remains to elucidate. The expression of iASPP in chordoma tissues and cells, its correlation to clinicopathological parameters and the effect on the patients’ prognosis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Ma, Yunlong, Zhu, Bin, Liu, Xiaoguang, Liu, Zhongjun, Jiang, Liang, Wei, Feng, Yu, Miao, Wu, Fengliang, Zhou, Hua, Xu, Nanfang, Liu, Xiao, Yong, Lei, Wang, Yongqiang, Wang, Peng, Liang, Chen, He, Guanping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5620263/
https://ncbi.nlm.nih.gov/pubmed/28978123
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20190
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak